MSCopilot

Monitor your MS

Only for iPhone

Free

iPhone

The first clinically validated medical device to monitor MS progression. MSCopilot is a software medical device dedicated to people living with Multiple Sclerosis (MS). Designed by Ad Scientiam in collaboration with patients and MS medical experts, it aims to improve disease monitoring and the quality of your care, complementing your standard medical follow-up. MSCopilot helps you better understand your symptom progression over time and supports informed decision-making in collaboration with your healthcare professionals. The patient mobile app allows you to perform regular, clinically validated digital tests at home to evaluate key motor, cognitive, and visual symptoms. Your results are transferred in real time to a secure dashboard for your healthcare professionals, who can rely on this objective data during your consultations. Free to use, MSCopilot offers personalized support while strictly respecting health data security. KEY FEATURES • Regular symptom tracking – Active tests for walking, dexterity, cognition, and low-contrast vision • Assessment of MS impact on daily life – Validated questionnaires for fatigue and mental health • Progression visualization – Clear and accessible data history • Medical consultation support – Data accessible on your healthcare professionals' dashboard to facilitate discussions • Personalized reminders – Notifications to remind you to complete your tests and questionnaires • Security & Privacy – Health data hosting and management compliant with regulatory requirements (GDPR, HIPAA) TARGET AUDIENCE • People with Multiple Sclerosis • Healthcare professionals involved in MS care • MS care and monitoring facilities REGULATORY INFORMATION Ad Scientiam processes only the data necessary for monitoring your pathology. Your agreement is essential before any data processing. No data processing is performed without your consent. You can access the data we collect at any time through our data protection policy. The assessments provided in MSCopilot are based on methodologies derived from the scientific literature and evaluated in clinical settings. Scientific references: DOI:10.1016/j.msard.2021.103164, DOI:10.1111/ene.14091.

  • This app hasn’t received enough ratings or reviews to display an overview.

The developer, Ad Scientiam, indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy .

  • Data Linked to You

    The following data may be collected and linked to your identity:

    • Health & Fitness
    • Location
    • Contact Info
    • User Content
    • Identifiers
  • Data Not Linked to You

    The following data may be collected but it is not linked to your identity:

    • Health & Fitness
    • Diagnostics

Privacy practices may vary, for example, based on the features you use or your age. Learn More

The developer has not yet indicated which accessibility features this app supports. Learn More

Seller
  • Ad Scientiam
Size
  • 59.2 MB
Category
  • Medical
Compatibility
Requires iOS 16.0 or later.
  • iPhone
    Requires iOS 16.0 or later.
Location
  • This app may use your location even when it isn’t open, which can decrease device battery life.
Languages
English and 6 more
  • English, Catalan, Danish, French, German, Italian, Spanish
Age Rating
16+
  • 16+
  • This app is rated 16+ with content restrictions.

    Some content may be rated higher, and may therefore be restricted and managed by the developer through in-app controls.
  • In-App Controls
    Age Assurance

    Frequent
    Medical Treatment information
Medical Device
Yes
  • Ad Scientiam indicated this app is a regulated medical device and complies with United States law.
  • The information below has not been verified by Apple.
  • FDA Owner/Operator Number
  • 10095255
  • Address
  • 38 rue Dunois
    75647 PARIS
    France
  • Phone Number
  • +33 1 78 95 71 92
  • Email
  • privacy@adscientiam.com
  • Use Statement
  • MSCopilot® is a software as a medical device consisting of a mobile application running on smartphones, a cloud computing platform and a web portal.
    The mobile application is intended to be used by patients living with Multiple Sclerosis (PwMS) in their home environment. The application is used for data collection through unsupervised functional tests and electronic questionnaires. The functional tests assess walking perimeter, walking speed, hand function, low contrast visual acuity and cognitive processing time. The e-questionnaires assess fatigue and depression. Results are not intended to be interpreted by the patients themselves.
    The main benefit of MSCopilot is to track objective measures of these key symptoms between consultations to improve MS patients' management by their healthcare professionals. Patients' clinical benefits rely on telemonitoring of functional tests analogous to modified MSFC, giving them access to a non-routine clinical test that covers dimensions not taken into account with routine clinical tests (EDSS).
  • Safety Information
  • The test results provided by the MSCopilot® mobile application are for information purposes only and should only be interpreted in the presence of a healthcare professional.
    The use of MSCopilot® is not recommended for people with a neurological disease other than Multiple Sclerosis and for patients with a physical or mental incapacity to use a smartphone.
    Do not use MSCopilot® on a damaged smartphone (cracked or broken glass for instance) as this could compromise the measurement performance of the device.
    Always use a secured network for internet connection with sufficient standard of protection (for instance, WPA, WPA2 or WPA3 if you use WiFi)
  • Instructions for Use
  • Visit the developer site
Copyright
  • © 2026, Ad Scientiam